LYFT Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? LYFT Inc trades at $16.15 (market cap $5.90B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 4.3× LYFT Inc's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, LYFT Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold LYFT Inc for 47 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| LYFT | ROIV | |
|---|---|---|
Market Cap | $5.90B | $25.09B |
Volume | 9,741,129 | 5,738,571 |
Sector | Technology | Health |
52-Week High | $24.57 | $41.81 |
52-Week Low | $12.65 | $16.04 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | $5.37B | $21.36B |
Signals from Pluang's Aura AI — not financial advice
Lyft trades at $16.13, up 2.35% on the day, with a bullish technical signal from moving averages but a neutral stance from oscillators. The company reported strong revenue growth to $6.32B in 2025 and a net income of $2.84B, though recent quarterly EPS results have missed expectations. Positive developments include European expansion and a partnership with Sphere, while a $272.5M legal settlement poses a headwind.
The outlook is mixed; low P/E and P/S ratios suggest undervaluation, and analyst consensus targets $18.07, but execution risks and competitive pressures remain. Earnings consistency is key for sustained upside, with the stock offering value if growth momentum continues despite near-term volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →